Evidence map›Paper›PMID 25814227›Full record

ArticleJournal of the American College of Cardiology2015

Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy.

Khaushik Subramanian, Davide Gianni, Cristina Balla, Gabriele Egidy Assenza, Mugdha Joshi, Marc J Semigran, Thomas E Macgillivray, Jennifer E Van Eyk, Giulio Agnetti, Nazareno Paolocci and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Alterations in the inflammatory homeostasis of aging-related cardiac dysfunction and Alzheimer's diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Khaushik SubramanianCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Davide GianniCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Cristina BallaCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Cardiology, Sapienza University, Rome, Italy.
Gabriele Egidy AssenzaDivision of Cardiology, Sapienza University, Rome, Italy.
Mugdha JoshiDivisions of Newborn Medicine and Genetics and Program in Genomics, Children's Hospital, Boston, Massachusetts.
Marc J SemigranHeart Center, Massachusetts General Hospital, Boston, Massachusetts.
Thomas E MacgillivrayCardiovascular Surgery, Massachusetts General Hospital, Boston, Massachusetts.
Jennifer E Van EykNational Heart Lung Blood Institute Proteomics Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Giulio AgnettiNational Heart Lung Blood Institute Proteomics Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
Nazareno PaolocciHeart and Vascular Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
James R BamburgDepartment of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado.
Pankaj B AgrawalDivisions of Newborn Medicine and Genetics and Program in Genomics, Children's Hospital, Boston, Massachusetts.
Federica Del MonteCardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Heart Center, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: fdelmont@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USJohns Hopkins University · USBoston Children's Hospital · USMassachusetts General Hospital · USColorado State University · USSapienza University of Rome · IT

Funding

Proteomic Profiling of CFTR Protein InteractionR01HL079442 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI BALCH, WILLIAM EDWARD, YATES III, JOHN R · 2005 to 2014
$4.6M
Role of Presenilin in Idiopathic Dilated CardiomyopathyR01HL098468 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DEL MONTE, FEDERICA · 2010 to 2013
$1.7M
Cofilin-2: Molecular Function and it's Role in MyopathiesK08AR055072 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI AGRAWAL, PANKAJ B · 2007 to 2011
$633k
Mechanisms of misfolded protein toxicity in idiopathic Dilated Cardiomyopathy andR21HL102716 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DEL MONTE, FEDERICA · 2010 to 2011
$478k
NHLBI NIH HHS R01 HL079442NHLBI NIH HHS R01 HL098468NHLBI NIH HHS R01HL098468NHLBI NIH HHS R21 HL102716NHLBI NIH HHS R21HL102716NIAMS NIH HHS K08 AR055072
6 · The paper itself

Abstract

backgroundRecently, tangles and plaque-like aggregates have been identified in certain cases of dilated cardiomyopathy (DCM), traditionally labeled idiopathic (iDCM), where there is no specific diagnostic test or targeted therapy. This suggests a potential underlying cause for some of the iDCM cases. [Corrected]

objectivesThis study sought to identify the make-up of myocardial aggregates to understand the molecular mechanisms of these cases of DCM; this strategy has been central to understanding Alzheimer's disease.

methodsAggregates were extracted from human iDCM samples with high congophilic reactivity (an indication of plaque presence), and the findings were validated in a larger cohort of samples. We tested the expression, distribution, and activity of cofilin in human tissue and generated a cardiac-specific knockout mouse model to investigate the functional impact of the human findings. We also modeled cofilin inactivity in vitro by using pharmacological and genetic gain- and loss-of-function approaches.

resultsAggregates in human myocardium were enriched for cofilin-2, an actin-depolymerizing protein known to participate in neurodegenerative diseases and nemaline myopathy. Cofilin-2 was predominantly phosphorylated, rendering it inactive. Cardiac-specific haploinsufficiency of cofilin-2 in mice recapitulated the human disease's morphological, functional, and structural phenotype. Pharmacological stimulation of cofilin-2 phosphorylation and genetic overexpression of the phosphomimetic protein promoted the accumulation of "stress-like" fibers and severely impaired cardiomyocyte contractility.

conclusionsOur study provides the first biochemical characterization of prefibrillar myocardial aggregates in humans and the first report to link cofilin-2 to cardiomyopathy. The findings suggest a common pathogenetic mechanism connecting certain iDCMs and other chronic degenerative diseases, laying the groundwork for new therapeutic strategies.

Indexed as

Gene Expression RegulationAdultAgedAnimalsCardiomyopathy, DilatedCofilin 2FemaleFrozen SectionsHeart TransplantationHumansMaleMiceMice, KnockoutMiddle AgedMyocardiumPhosphorylationCofilin 2adenovirusheart failurenemaline

Identifiers

PMID25814227
PMCPMC4379451
OpenAlexW258103872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.